Alkem Laboratories Limited
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
What Alkem files
- Others96
- Investor Meet62
- Updates42
- Important22
- PPTs11
- Board Meeting11
Alkem Laboratories clarified an XBRL filing discrepancy for Q4 FY25 results. The original submission incorrectly stated "audited" results. The company has now submitted a revised XBRL (standalone and consolidated), correcting this technical error. This does not change the reported financial figures.
Alkem Laboratories has announced a board meeting to review the financial results for the quarter and nine months ended 31 December 2024. The consolidated revenue from operations rose to ₹33,742.8 crore, while profit after tax registered at ₹6,407.9 crore. Notably, the company declared an interim dividend of ₹37 per equity...